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Distinct Molecular Signature of Human Skin
Langerhans Cells Denotes Critical Differences
in Cutaneous Dendritic Cell Immune Regulation
Marta E. Polak1, Stephen M. Thirdborough2, Chuin Y. Ung1, Tim Elliott2, Eugene Healy1, Tom C. Freeman3 and
Michael R. Ardern-Jones1
Langerhans cells (LCs) are professional antigen-presenting cells (APCs) residing in the epidermis. Despite their
high potential to activate T lymphocytes, current understanding of human LC biology is limited. Genome-wide
comparison of the transcriptional profiles of human skin migratory CD1aþ LCs and CD11cþ dermal dendritic
cells (DDCs) demonstrated significant differences between these ‘‘dendritic cell (DC)’’ types, including
preferential expression of 625 genes (Po0.05) in LC and 914 genes (Po0.05) in DDC. Analysis of the temporal
regulation of molecular networks activated after stimulation with tumor necrosis factor-a (TNF-a) confirmed the
unique molecular signature of LCs. Although LCs conformed to the phenotype of professional APC, inflammatory
signaling activated primarily genes associated with cellular metabolism and mitochondrial activation (e.g., CYB561
and MRPS35), cell membrane re-organization, and antigen acquisition and degradation (CAV1 and PSMD14;
Po0.05–Po0.0001). Conversely, TNF-a induced classical activation in DDCs with early downregulation of surface
receptors (mannose receptor-1 (MRC1) and C-type lectins), and subsequent upregulation of cytokines,
chemokines (IL1a, IL1b, and CCL18), and matrix metalloproteinases (MMP1, MMP3, and MMP9; Po0.05–
Po0.0001). Functional interference of caveolin abrogated LCs superior ability to cross-present antigens to
CD8þ T lymphocytes, highlighting the importance of these networks to biological function. Taken together,
these observations support the idea of distinct biological roles of cutaneous DC types.
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INTRODUCTION
Skin-resident dendritic cells (DCs), including epidermal Lan-
gerhans cells (LCs), orchestrate cutaneous immune responses
while helping to maintain tissue homeostasis (Banchereau
et al., 2003; Polak et al., 2012; Seneschal et al., 2012a). LCs
are located in the epidermis and are able to use their dendrites
to reorganize upper epidermal tight junctions, allowing
constant sampling of the tissue and environment (Kubo et al.,
2009). They can acquire particulate antigens via phagocytosis
and endocytosis ( Sagebiel, 1972; Kubo et al., 2009) and
facilitate antigen uptake with surface receptors including
C-type lectin, Langerin (Valladeau et al., 2000) and CD205
(Santegoets et al., 2008; Flacher et al., 2010). As a result of
antigen uptake, LCs can stimulate efficient primary and
secondary immune responses to viral antigens, including
influenza (Klechevsky et al., 2008, 2010), Epstein–Barr virus
(EBV; Polak et al., 2012), measles (van der Vlist et al., 2011),
mycobacteria (Hunger et al., 2004), and fungi (de Jong et al.,
2010). However, LC interactions with pathogens are not limited
to activation of antigen-specific T lymphocytes, as Langerin-
mediated uptake of human immunodeficiency virus by LCs
results in efficient degradation of viral particles, and thus
induces protection against human immunodeficiency virus
infection (de Witte et al., 2007). LC maturation is likely to be
critical for efficient induction of T-cell responses (Grabbe et al.,
1992; Banchereau et al., 2003; van der Vlist et al., 2011; Polak
et al., 2012). The maturation signals come from LC cross-talk
with surrounding tissue, e.g., tissue-derived pro-inflammatory
cytokines, including tumor necrosis factor-a (TNF-a; Ratzinger
et al., 2004; Berthier-Vergnes et al., 2005; Polak et al., 2012),
thymic stromal lymphopoietin (Ebner et al., 2007; Nakajima
et al., 2012), and tumor growth factor-b (Geissmann et al.,
1999; Bauer et al., 2012), danger-associated molecular patterns
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(Kool et al., 2011) and recognition of pathogen-derived
signals, including pathogen-associated molecular patterns
(Peiser et al., 2008; Tang et al., 2010).
LCs anatomical location in the outermost part of the skin
and mucosal tissue combined with their classical DC capacity
for antigen capture, processing, and presentation make a
strong case for them acting as the primary gatekeepers against
infection and other exogenous pro-inflammatory stimuli.
However, the immunostimulatory role of LCs, as compared
with dermal DCs (DDCs) in cutaneous immunity has been
much debated (Zhao et al., 2003; Ritter et al., 2004; Bennett
et al., 2005; Kaplan et al., 2005; Noordegraaf et al., 2010;
van der Aar et al., 2013). Recently, along with others, we
have demonstrated that the direct interactions within the
immunological synapse are critically important for human
LCs’ capacity to stimulate CD8 T lymphocytes (van der Aar
et al., 2011; Banchereau et al., 2012; Polak et al., 2012) To
better understand the molecular mechanisms regulating LC
function, we undertook microarray analysis of gene expression
changes in two subsets of migratory DCs isolated directly from
human skin: CD1aþ epidermal LCs and CD11cþ DDCs
(Zaba et al., 2007; Teunissen et al., 2012), immediately after
isolation and over a time course stimulation in culture with
TNF-a, an epidermal pro-inflammatory cytokine. The results of
transcription network analysis, validated by functional assays,
clearly show distinctively different transcriptional profiles of
these two skin-derived antigen-presenting cells (APCs), and
denote the key role of protein metabolism and antigen
processing in LC biology.
RESULTS
Molecular and functional analysis of migratory CD1aþ
epidermal LCs and CD11cþ dermal DDCs
LCs and DDCs isolated by migration over 48 hours from
human skin (termed ‘‘migratory’’) were 85%–96% CD1aþ /
HLA-DRþ (LC) and 82–90% CD11Cþ /HLA-DRþ (DDC) as
assessed with flow cytometry (Figure 1 a and b). Expression of
markers classically associated with LC (CD207—langerin,
CD205/DEC205) and DDC (FXIIIa, and mannose receptor-1
(MRC1), CD14, CD163, CD209 and C-type lectins:
CLEC10A, CLEC2B, and CLEC4E) in unstimulated cells was
confirmed by microarrays (Figure 1c). As expected, all skin
DCs exhibited the molecular signature of a professional APC,
including high expression levels of genes involved in antigen
presentation to T cells: HLA class I and II, b2 microglobulin
(B2M) and class II HLA transactivator (CIITA), and co-
stimulatory molecules (CD40, CD80, and CD86;
Supplementary Figure S1a–c online). Using a well-defined
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Figure 1. Skin migratory CD1aþ Langerhans cells (LCs) and CD11cþ dermal dendritic cells (DDCs) are professional antigen-presenting cells. (a, b) Flow
cytometric staining of human skin isolated, bead-purified migratory (a) LC and (b) DDC. Representative example. (c) Log2(x) expression of DC markers in
unstimulated LCs and DDCs, microarray analysis (n¼ 3 independent skin donors, in duplicate). (d–f) CFSE dilution assay of Epstein–Barr virus (EBV)–specific
HLA-matched CD8þ T-cell line stimulated by EBV-peptide (d) or with EBV-peptide pulsed LCs (e) or DDCs (f). (g) IFN-g ELISpot assay of EBV-specific
CD8þ activation by 9-amino-acid EBV-peptide pulsed LCs (black bar) or DDCs (grey bar). (n¼ 3). (h) IFN-g ELISpot assay of 39-amino-acid EBV-specific
CD8þ activation by EBV-long peptide pulsed LCs (black bar) or DDCs (grey bar). (n¼ 3, unpaired t-test; ***Po0.005). CFSE, carboxyfluorescein succinimidyl
ester; FSC, forward scatter; NS, not significant; SFU, spot forming units; SSC, side scatter.
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HLA-A2 EBV epitope, we confirmed that both mature LCs and
DDCs pulsed with specific peptide efficiently induced A2
EBV-specific CD8þ cell proliferation (Figure 1d–f) and
activation (Figure 1g). By fusing the same epitope into a 39-
amino-acid long peptide, requiring antigen processing for
presentation on HLA-A2, we confirmed that only LCs showed
significant ability to cross-present antigens as we have
reported previously (Polak et al., 2012; Figure 1h).
LC and DDC transcriptomes are distinctively different
To investigate the molecular mechanisms underpinning the
functional superiority of LC to cross-present antigens during
maturation and pro-inflammatory conditions, we analyzed
the transcriptome of CD1aþ LCs and CD11cþ DDCs over
a 24-hour time course of stimulation with an epidermal pro-
inflammatory cytokine, TNF-a. Multidimentional scaling ana-
lysis (Figure 2a) and sample-to-sample clustering (BioLayout
Express3D, Figure 2b) of the transcriptomes of CD1aþ LCs and
CD11cþDDCs indicate that the gene expression profile of LCs
are quite distinct from DDC. In addition, over 24-hour stimula-
tion with TNF-a, while CD11cþ DDC showed clear evidence
of an ongoing adaptation of transcription throughout the time
period, LCs displayed only minor changes to their transcrip-
tional profiles (Figure 2b; Supplementary Table S1 online).
Characterization of the biological processes in migratory LCs
and DDCs
Genome-wide transcriptome comparison of unstimulated LCs
and DDCs identified 969 probesets (625 genes) preferentially
expressed in LC, and 1,648 probesets (914 genes) preferen-
tially expressed in DDC (1.5-fold difference in log2(x) robust
multichip average (RMA)-normalized expression level
between the cell types; Supplementary Table S1 online). To
determine the biological processes specific to CD1aþ LCs and
CD11cþ DDCs, these lists of genes were submitted to
DAVID bioinformatic database analysis (Huang da et al.,
2009a, b; Supplementary Table S2 online). Both LC and
DDC were sensitive to TNF-a signaling. However, although
DDCs overexpressed TNFRSF10A, TNFRSF10B, TNFRSF10D,
TNFESF14 and TNFRSF21, LC highly expressed two isoforms
of TNFRSF11 (A and B) and TNFRSF8. The biological function
of migratory LCs was strikingly different to DDCs, as pre-
dicted by DAVID functional gene classification and func-
tional annotation. Migratory DDC expressed multiple genes
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Figure 2. CD1aþ Langerhans cell (LC) and CD11cþ dermal dendritic cells (DDCs) show distinctively different pattern of gene expression. Visual
representation of whole transcriptome analysis of CD1aþ LCs and CD11cþ DDCs (n¼3 independent skin donors, time course (0, 2, 8, and 24 hours) of
stimulation with tumor necrosis factor-a (TNF-a)). (a, b) Sample-to-sample clustering. (a) Multidimensional scaling analysis, LC (right quadrants) and DDC
samples (left quadrants) as indicated. Kruskal’s stress 0.099 for two-dimensional scaling. (b) Sample-to-sample clustering of CD1aþ LCs and CD11cþ DDCs
expression profiles (BioLayout Express3D, correlation coefficient (r)¼ 0.96, Markov clustering algorithm (MCL)¼2.2). Lines (edges) represent the similarity between
samples. Circles (nodes) represent transcriptomes measured at different time points. (c) Transcript-to-transcript clustering, (BioLayout Express3D, r¼ 0.85;
MCL¼ 1.7) of 2,334 probesets differentially regulated by TNF-a. Lines (edges) represent the similarity between transcripts; circles (nodes) represent genes.
(d–f) Mean (±SEM) expression profiles for clusters 1–14, LC (black bars) and DDC (grey bar).
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typically associated with immune responses, involved in
cytokine–cytokine receptor interactions, chemokine signaling
pathways, Toll-like receptor signaling pathway, and Fc-g
receptor-mediated phagocytosis (Supplementary Table S2
online). DDC expressed a broad spectrum of receptors, inclu-
ding pathogen recognition-associated cell surface receptors
(Figure 1c). Many of the DDC-overexpressed genes involved
in signal transduction were directly involved in immune
signaling (ABCA1, GEM, IRAK3, KL, NDRG1, and PYCARD).
The DDC effector genes included abundant immune media-
tors (including complement proteins and low levels of cyto-
kines and chemokines). In contrast, the majority of genes ove-
rexpressed in migratory LC were involved in cytoskeleton
reorganization and membrane re-modeling (ACTB, CNN,
DSP, ANK3, PFN1, SYNPO, and PLEK2), endocytosis and
intracellular transport (AP1B1, AP2S1, SH3KBP1, SNX4,
and SNX7), proteolysis (FBXO2, PSMC3, UCHL3, USP46,
and TRIM32), and mitochondrial activity (ACOT1, ACOT7,
ACOX3, CYB561, NDUFB7, and NQO1). Biological path-
ways identified in LC were involved primarily in cell meta-
bolism (KEGG pathways annotation). LC preferentially
expressed a small number of receptors, including CD207
(langerin), lipoprotein receptors (LSR and LDLR), and only a
handful of genes primarily involved in immune processes
(CCL22, CD70, CLU, COTL1, HLA-DQA, and TAPBL; the full
list of genes preferentially expressed in LCs and DDCs:
Supplementary Table S2 online).
Migratory skin DCs and trypsinized skin DCs demonstrate
strongly matching transcriptomes
To confirm the relevance of these findings to the in vivo
situation, we also challenged our model system against whole
transcriptome data from DCs rapidly isolated from skin using a
trypsinization protocol (Santegoets et al., 2008; Allen et al.,
2010; Hutter et al., 2012; Harman et al., 2013; Supplementary
Table S3 online). Comparison of the genes differentially
expressed in either LCs or DDCs revealed the same pattern
of expression in both the migratory and trypsinized models
(Supplementary Figure 2 online). Furthermore, gene set
enrichment analysis (Subramanian et al., 2005) of T0 LCs
(n¼ 18 data sets), confirmed that migratory LC genes of
interest were also significantly enriched in trypsinized
LCs, enrichment score¼ 0.55, Po0.02 and enrichment
score¼0.42, Po0.0019, enrichment score¼0.52, Po0.01
(Supplementary Table S3 1, 2, and 3 online) respectively, as
compared with DDC. Similarly, gene expression in migratory
DDC populations were replicated in trypsinized DDCs,
(enrichment score¼ 0.78, Po0.05) in comparison with tryp-
sinized LCs. As seen in migratory LCs, DAVID functional gene
classification and functional annotation of genes of increased
expression in trypsinized LCs were involved in cell-to-cell
adhesion, mitochondrial function, and metabolism, and
trypsinized DDCs reflected migratory DDCs showing
overexpressed genes involved in receptor-mediated
pathogen uptake, cytokine signaling, and immune responses
(Supplementary Figure S2 online; Supplementary Table S4
online). However, some differences between migratory and
trypsinized cells were evident. As predicted, in comparison
with trypsinized cells, migratory LCs showed reduced (but not
absent) expression of cell adhesion molecules, increased
proteasome activity, and upregulation of the expression of
co-stimulatory molecules. This suggests that despite acquiring
a T-cell activatory phenotype and immunological maturation,
the overall genetic profile underpinning their biology
remained similar. Migratory and trypsinized DDCs showed
very closed resemblance. Upon migration, they further upre-
gulated and extended their scavenging and pro-inflammatory
characteristics.
Activation of human skin APCs with the pro-inflammatory
cytokine TNF-a results in temporal coordination of immune-
related gene transcription in DDCs, but not in LCs
To investigate transcriptional events during activation of skin
LCs and DDCs, we reconstructed networks of co-regulated
genes in BioLayout Express3D (Pearson coefficient cutoff
r¼ 0.85, Markov clustering algorithm inflation value¼ 1.7)
over a time course of stimulation with TNF-a for 2,334
probesets showing 41.5-fold difference in log2(x) RMA-
normalized gene expression levels in comparison with un-
stimulated cells (Bayesian estimation of temporal regulation
cutoff threshold P¼ 0.05, Aryee et al., 2009). The resultant
gene transcription network diagram was highly organized and
comprised of two main loosely connected network structures,
representing genes expressed in a cell type-specific manner:
the top part of the diagram contained genes preferentially
expressed in LC, bottom part in DDC (Figure 2c–f). More than
90% of transcripts were expressed differentially in LCs and
DDCs, including 1,859 genes regulated by TNF-a selectively
in DDCs and 306 genes selectively in LC. The separate
grouping of TNF-a regulatory networks in DDCs and LCs
supported a dramatic functional and temporal discordance
between these two cell types (Figure 2c). To understand the
biological events during the temporal regulation with TNF-a,
the gene network was clustered using Markov clustering
algorithm (inflation value¼1.7). This identified 13 clusters
of genes expressed preferentially in DDCs, 12 clusters group-
ing genes expressed preferentially in LC, and 6 small clusters
containing genes regulated in the same manner in both cell
types (Figure 2). The analysis of biological processes enriched
in the genes grouped within 14 largest clusters (containing
1,887 transcripts) demonstrated that seven of them (clusters
01, 02, 04, 06–09) contained genes predominantly involved in
inflammatory responses that were highly expressed in DDCs
in contrast to LCs (Figure 2c and d; Supplementary Figure S2
online, Supplementary Table S5 online). The dynamics of
gene expression in these clusters recapitulate the typical
myeloid DC activation pattern (Banchereau et al., 2003).
Upon activation, DDCs downregulated surface cell recep-
tors, associated with antigen capture, and reduced phago-
cytosis (clusters 01 and 08, including CD163, C-type lectin
receptors CLEC1A, CLEC4G, CLEC5A, CLEC7A, CXCL2, and
CXCR7 and FC-g receptors FCGR2A, FCGR2B, and FCGR3A),
whereas expression of genes involved in transcription,
intracellular signaling, and cytokine synthesis peaked at
2 hours (cluster 02; e.g., CREM, RPL28, TNF, IL7, IL1RN,
CXCR4, CCL3, CCL4, DYRK-3, RIPK1, MAPK2K3, ZNF36,
ME Polak et al.
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and ZNF295) followed by an upregulation of genes involved
in synthesis and secretion of a wide range of cytokines and
chemokines, matrix metalloproteinases (MMPs, known to be
involved in rearrangement of extracellular matrix), and
regulators of cell migration between 8 and 24 hours (clusters
04, 06, 07, and 09; e.g., IL1A, IL23A, MMP1, MMP7, MMP9,
MMP14, CCL1, CCL2, CCL17, CCL18, CCL24, and CXCL6,
Figure 2c and d; Supplementary Figure S3 online;
Supplementary Table S5 online).
In contrast, LCs showed low levels of DDC gene cluster
expression and the changes induced by stimulation with
TNF-a were minimal. The six biggest LC-associated clusters
(03, 05, 10, 12–14, Figure 2c and e) grouped genes relatively
highly expressed in un-stimulated cells, and activation with
TNF-a had a proportionally lesser effect on gene expression
changes in LCs as compared with gene changes induced in
DDCs. During the stimulation with TNF-a, LC downregulated
the catabolism of carbohydrates and fatty acids (cluster 05),
and increased expression of proteins involved in endocytosis,
intracellular transport, and signaling, protein degradation,
including genes coding for proteasome assembly units and
protein degradation enzymes (clusters 03, 12, and 14). TNF-a
signaling also altered LC mitochondrial function, inducing
high expression levels of mitochondrial ribosomal protein
expression (for individual gene profiles, see Supplementary
Figure S4 online). Interestingly, genes involved in mitosis
could also be identified in all LC-associated clusters, support-
ing the hypothesis of a self-repopulating ability previously
postulated for LCs (Hemmerling et al., 2011; Kanitakis et al.,
2011). Perhaps surprisingly, only a limited number of genes
typically associated with immune responses were
preferentially upregulated in LCs following TNF-a, including
IL15 and CCL22 (cluster 03; Figure 3a and c; Supplementary
Figure S4 online; Supplementary Table S5 online). However,
among the genes upregulated in LCs during stimulation with
TNF-a, and positioned separately from the core myeloid DC
clusters (clusters 03, 12, and 14, Figure 2c and e), we
identified several genes primarily associated with cytoskeleton
organization, but which have also been reported in immune
responses or immune signaling, including SNX 11 (sorting
nexin 11; cluster 12) and SYNPO (synaptopodin; cluster 14).
Cluster 14 genes, such as CAV1, link processes of antigen
acquisition and regulation of immune responses, including
genes involved in endocytosis, cytoskeleton reorganization,
and regulation of signal transduction (PTPRK).
Genes regulated in the same manner in LCs and DDCs were
less frequent (243 transcripts), and grouped in six smaller
clusters, including cluster 11 (Figure 2c and f). These included
genes associated with nucleus, RNA processing and transcrip-
tion, cytoskeleton, cobalamin biosynthesis, hemopoiesis, and
leukocyte development. The interactive three-dimensional
map of skin migratory DC transcriptome is available at
http://www.macrophages.com/LC_vs_DC.
Caveolin-1 dependency of LC cross-presenting function
LC-associated molecular networks clearly indicated a relation-
ship between TNF-a signaling and induction of genes grouped
in clusters 03, 12, and 14. To confirm their dependence
on TNF-a, in contrast to immune-related gene expression,
we validated the TNF-a induced upregulation of CAV1
and PMSD14 in LCs versus DDCs by quantitative PCR
(Figure 3a–d) in cells isolated from three independent skin
donors. In contrast, CCL18 was uniquely upregulated in DDC
(Figure 3e and f). The gene expression pattern assessed by
quantitative PCR validated the microarray data (Figure 3b, d,
and f). Although proteasome function is indisputably asso-
ciated with antigen processing and presentation, we were
interested to test whether the increased expression of CAV1 in
LC might contribute to their superior cross-presenting facility.
Caveolin-1 function is specifically inhibited by filipin III (Yan
et al., 2004; Sato et al., 2012). We titrated filipin III concen-
trations against LC and DDC viability in overnight cell culture
and confirmed that this molecule is non-toxic at the
concentrations used (0.1–1mg ml–1; data not shown). Using
HLA-matched DCs pulsed with proGLC, inhibition of caveolin
with filipin III completely abrogated the ability of LCs to
cross-present antigens to EBV-specific CD8þ T lymphocytes
(Figure 3g).
DISCUSSION
LCs have long been recognized as key sentinels in human
cutaneous immunity, but recent experimental murine models
demonstrating their apparent redundancy in cutaneous
immune responses has called their role into question (Zhao
et al., 2003; Ritter et al., 2004; Bennett et al., 2005; Kaplan
et al., 2005; Noordegraaf et al., 2010). Previous work to
characterize the relative roles of human cutaneous DCs in the
skin have shown conflicting results, with some groups
reporting that LCs are the key APC inducing skin immunity
(Klechevsky et al., 2008; Flacher et al., 2010; van der Aar
et al., 2011; Banchereau et al., 2012; Polak et al., 2012), and
others the converse (de Witte et al., 2007; Santegoets et al.,
2008; Lundberg et al., 2013; van der Aar et al., 2013). Along
with others, we have previously demonstrated that LCs are
superior activators of CD8 T cells, due to differential signaling
via CD70 and their exceptional efficiency in cross-presenting
protein antigens to CD8 T cells (van der Aar et al., 2011; Polak
et al., 2012;) as well as IL-15 secretion directly into the
immune synapse (Banchereau et al., 2012). However, in
contrast to DCs derived from the dermis, LCs produce fewer
typical inflammatory mediators, including low levels of IL-1b
and IL-12p70 (Ratzinger et al., 2004; Munz et al., 2005;
Banchereau et al., 2012; Polak et al., 2012). In this study, we
aimed to undertake a comprehensive analysis, combining
transcriptomic assessment with functional readout to
characterize primary cutaneous DC function.
The data in this study show that transcriptomically, pheno-
typically, and functionally, both cutaneous DC populations
are professional APCs, as highlighted by high HLA-class I and
II expression and the ability to activate T lymphocytes. In
addition, these data help to explain the apparently conflicting
findings about LC function by different research groups: as can
be seen following stimulation with TNF-a, read-outs of
inflammatory mediators, or ‘‘activation-status’’ are likely to
show lower levels in LCs, whereas functional assessments
demonstrate enhanced function. The distinctiveness of LC
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molecular networks indicates that not all tissue DC types
are biologically equal, and their biology is adapted to the
specific requirements of the local tissue microenvironment
(Hutter et al., 2012; Harman et al., 2013; Hume et al., 2013;
Lundberg et al., 2013). Direct comparison of the whole
transcriptomes of migratory cells and cells isolated rapidly
by trypsinization indicates that despite phenotypic immuno-
logical maturation, migratory cells retain the pattern of the
gene expression in steady-state, in particular high expression
of genes involved in cell metabolism, protein catabolism, and
cytoskeleton rearrangement in LCs as compared with DDCs,
as well as pronounced difference in expression of genes
involved in inflammatory responses between LCs and DDCs.
Although neither isolation technique perfectly reflects the
in vivo situation, and inevitably migration induced specific
phenotypic features including increased expression of co-
stimulatory molecules, we feel that the replication of the
same gene expression profiles in both migratory and tryp-
sinized cells as well as the evident changes on migratory cells
induced by TNF-a, justifies the analysis of these data to
explore the immunological signaling in cutaneous DCs.
However, we acknowledge that differences in the kinetics of
molecular signals induced by TNF-a are likely to exist in situ
as compared with in vitro. We would predict that these will be
especially important in relation to DC cross-talk with
tissue structural cells, e.g., maturation signal provided
by E-cadherin:E-cadherin between LC and keratinocytes
(Mayumi et al., 2013). The dichotomy between molecular
networks of human LCs and DDCs, recapitulating differences
in their biology, may reflect a different origin of these cell
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Figure 3. Genes organizing structure of biological membranes are important for Langerhans cell (LC) function. (a–f) Gene expression of CAV1 (a, b), PMSD14
(c, d), and CCL18 (e, f) in LC (black bars) or dermal dendritic cells (DDCs; grey bars) assessed by microarrays (a, c, e; robust multichip average (RMA) normalized)
and quantitative PCR (qPCR; b, d, f; expression normalized to house-keeping gene YWHAZ (2dCT) at various time points following stimulation with tumor
necrosis factor-a (TNF-a)). (g) IFN-g ELISpot assay of cross-presentation to Epstein–Barr virus (EBV)–specific CD8þ by LC treated with or without caveolin-1
inhibitor (filipin III). n¼ 3 independent skin donors. *Po0.05. SFU, spot forming units.
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types, as currently suggested by (Chorro and Geissmann,
2010; Hoeffel et al., 2012). Similarly, it is possible that the
distinctiveness of LC molecular networks is a direct result of
interactions between LCs, structural cells of the epidermis, and
the symbiotic microbiota during tissue resident differentiation
from ‘‘LC stem cells’’ (Merad et al., 2008; Sere et al., 2012). In
this environment, careful regulation to prevent overactivation
and harmful inflammatory responses under pro-inflammatory
conditions would be critical, particularly because
uncontrolled inflammation may lead to disruption of the skin
barrier and permit entry of infectious and noxious agents into
the body. Indeed, LC can utilize mechanisms preventing the
invasion of the micro-organisms, limit the presentation of
bacterial antigens, and maintain tissue homeostasis inducing
regulatory T cells in the steady state (de Witte et al., 2007;
Seneschal et al., 2012b; van der Aar et al., 2013). The
increased mitochondrial activation, indicating a higher
metabolic rate, as shown here might be an adaptation
specific to the epidermal microenvironment, which is low in
nutrient and oxygen because of the lack of vasculature. Such a
potentiated metabolism would also benefit LC in hydrolysis of
a variety of macromolecules from pathogenic organisms,
including bacterial cell walls and fungi. As modeled here in
skin migratory cells, in the inflammatory conditions, e.g.,
when in situ LCs are exposed to pro-inflammatory cytokines,
like TNF-a, the enhanced endocytosis, proteasomal
degradation, and intracellular transport (clusters 03, 12, and
14), alongside the decreased metabolism of macromolecules
(cluster 05), would result in increased antigen presentation
and activation of adaptive immune responses.
In conclusion, LCs are APCs with all the appropriate
machinery for this purpose, but in contrast to DDCs are highly
efficient at presentation and cross-presentation of antigen, and
the data in this study provide evidence that this is mediated by
key differences in gene expression, which regulates antigen
uptake and processing. Furthermore, the relative constancy of
the LC molecular network following activation by TNF-a,
suggests a more differentiated cell type that may reflect a key
evolutionary need for different functional roles related to tissue
compartmentalization. In addition, our findings support the
idea that LCs represent an attractive proposition for targeted
immunological intervention. Topical or micro-needle vaccine
delivery may be expected to preferentially target LCs, thereby
promoting a strong CD8þ immune response, as indeed was
demonstrated for transcutaneous influence vaccination
(Combadiere et al., 2010). The ability of LCs both to prime
naive CD8 T cells (Banchereau et al., 2012) and to potently
activate memory CD8 T-cell responses (Polak et al., 2012;
Seneschal et al., 2012b; van der Aar et al., 2013) renders these
cells suitable as targets for induction of both systemic and
skin-homing immune responses.
MATERIALS AND METHODS
Isolation and culture of human skin migratory DCs
Skin specimens and blood samples were acquired from healthy
individuals after obtaining informed written consent with approval
by the Southampton and South West Hampshire Research Ethics
Committee in adherence to Helsinki Guidelines. Primary cutaneous
DCs were isolated as described previously (Polak et al., 2012).
Migratory epidermal and dermal DCs were purified with magnetic
beads according to the manufacturer’s protocol (epidermal cells:
CD1aþ , dermal cells: CD11cþ , Miltenyi Biotec, Bisley, UK). Cells
were assayed for yield and cell viability, and unstimulated cells (time
0, 250,000/cell type/donor) were harvested immediately. For analysis
of changes in gene expression upon activation, DCs were stimulated
with TNF-a (25 ng ml–1, Miltenyi Biotec) for 2, 8, and 24 hours
(250,000 cells/cell type/donor/time point). Harvested cells were
cryopreserved at  80 1C in RLT buffer (Qiagen, Manchester,
UK)þ 1% b-mercaptoethanol. DC pulsing with EBV-derived
peptides, EBV-peptide-specific T-cell expansion and ELISpot assays
were performed as described previously (Polak et al., 2012).
Genechip microarray data analysis
RNA was isolated using RNeasy mini kits (Qiagen) as per the
manufacturer’s protocol. RNA concentration and integrity was deter-
mined with an Agilent Bioanalyser (Agilent Technologies, Santa
Clara, CA). All the samples had a RNA integrity number of 7.0 or
above and were taken forward for labeling. Gene expression analysis
was carried out using the Human Genome U-219 Affymetrix platform
by ARK-Genomics Centre, The Roslin Institute, Edinburgh, UK.
Expression data were normalized using the RMA package within
the Affymetrix expression console package and annotated. After an
initial QC check, the data were taken forward for analysis. Microarray
data GEO accession number: GSE49475.
Comparison of skin DC transcriptomes. Unfiltered RMA-normal-
ized microarray data were analyzed using multidimensional scaling.
The proximity matrix was created on the basis of Euclidean distance
dissimilarities calculation (XLstat, Addinsoft, New York, NY) for 2, 3,
and 4 dimensions. In addition, a sample-to-sample Pearson correla-
tion matrix was calculated using BioLayout Express3D and the
resultant graph of relationships of r40.96 was visualized. For
comparison of migratory with enzymatically digested skin, DCs raw
data (.cel) files from human skin LCs and DDCs data sets available in
GEO database (http://www.ncbi.nlm.nih.gov/geo/; Supplementary
Table S3 online) were used and processed as previously described
(Mabbott et al., 2010). Owing to the pronounced study-related batch
effect only LCs and DDCs from GSE23618 were compared directly
with our migratory cell data set (Hierarchical Clustering Explorer,
University of Maryland), whereas GSE16395 and GSE35340 LCs were
assayed for the presence of identified gene signatures using gene set
enrichment analysis (Subramanian et al., 2005).
Statistical identification of differentially expressed genes and
network analysis. To identify genes regulated by exposure of skin
DCs to TNF-a, a cutoff threshold 0.05 of Bayesian estimation of
temporal regulation (Aryee et al., 2009) for genes showing X1.5-fold
difference between the maximum gene expression level and time 0
control in log2(x) RMA-normalized gene expression levels was
applied for both cell types. Using network analysis tool BioLayout
Express3D, a transcript-to-transcript correlation matrix was calculated
for 2,334 probesets fulfilling the criteria above, where each column of
data was derived from a different sample (donor/cell type/condition)
and each row of data represents an individual probeset (Freeman
et al., 2007). A non-directional network graph of the data was
generated for a Pearson correlation coefficient of rX0.85. In this
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context, nodes represent individual probesets (genes per transcripts)
and the edges between them Pearson correlation coefficients between
individual probesets above the threshold value. The network graph
was then clustered into groups of genes sharing similar profiles using
the Markov clustering algorithm within the BioLayout Express3D tool
with an Markov clustering algorithm inflation value (which controls
the granularity of clustering) set to 1.7, as reported previously
(Theocharidis et al., 2009).
Cluster annotation and analysis of gene expression profiles.
Gene set enrichment analysis was performed using the ‘‘functional
annotation clustering’’ tool, (similarity threshold 0.5, multiple linkage
threshold 0.5, EASE:1.0 and Benjamini correction) from DAVID
(Huang da et al., 2009a, b) web-based analysis tool and confirmed
by detailed direct analysis using Gene Expression Atlas (http://
www.ebi.ac.uk/gxa/). Average gene expression profiles for LC and
DDCs (four time points, in triplicate) were compared with two-way
repeated-analysis of variance for each cluster separately (GraphPad
Prism, La Jolla, CA) and P-values assessed with Bonferroni correction.
Validation of gene expression differences by quantitative PCR.
The expression of chosen genes was validated with quantitative
PCR, using the TaqMan gene expression assays for target genes:
YWHAZ (HS03044281_g1), CAV1 (Hs00971716_m1), PSMD14
(Hs01113429_m1), CCL18 (Hs00268113_m1) (Applied Biosystems,
Life Technologies, Paisley, UK) in cells isolated from three indepen-
dent skin donors. RNA extraction (RNeasy micro kit, Qiagen) and
reverse transcription (NanoScript kit; Primer Design, Southampton,
UK) were carried out accordingly to the manufacturer’s protocol. For
details, see Supplementary Materials and Methods online.
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